Stock listing

TPEx:6945 AP Biosciences, Inc. (圓祥生技) 股價

Follow AP Biosciences, Inc. into a list and get an email when it puts out news.

Share price · TPEX:6945

$97.20 TWD -22.80 (-19.0%)

Close on Nov 20, 2026

This year -23.8% · daily closes, Dec 1, 2025 – Nov 20, 2026, adjusted for splits
Day range
$97.20 – $102.50 TWDNov 20, 2026
Volume
379,351 sharesNov 20, 2026
Market cap
$9.30B TWDAt the close on Nov 20, 2026 · price × 95.70M shares outstanding
Traded on an average day
$45.18M TWDMedian day 274,124 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
AP Biosciences, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6945 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$97.20-22.80-19.0%$101.00$102.50$97.20379,351
$120.00-3.00-2.4%$127.00$127.00$117.50240,716
$123.00+8.50+7.4%$119.00$124.50$115.00509,651
$114.50-3.50-3.0%$124.50$127.00$112.50290,575
$118.00+4.00+3.5%$117.00$123.00$117.00201,796
$114.00-3.50-3.0%$118.00$119.00$114.00165,321
$117.50+2.50+2.2%$115.00$118.50$112.00157,948
$115.00+3.00+2.7%$115.00$117.50$112.00138,987
$112.000.000.0%$115.00$117.00$110.00160,991
$112.00-4.00-3.4%$104.50$118.00$104.50320,907
$116.00-7.00-5.7%$124.00$127.00$116.00421,185
$123.00-6.50-5.0%$131.50$131.50$122.50361,732
$129.50+2.50+2.0%$127.00$132.00$123.00368,603
$127.00-6.50-4.9%$132.00$133.50$127.00261,247
$133.50+0.50+0.4%$132.50$134.50$128.00335,652
$133.00-0.50-0.4%$131.50$134.00$129.00196,289
$133.50+1.50+1.1%$133.50$134.00$127.00288,912
$132.00+3.00+2.3%$128.00$134.50$125.00408,874
$129.000.000.0%$129.00$129.00$129.000
$129.00+11.50+9.8%$116.50$129.00$116.50554,102
$117.50-1.00-0.8%$119.50$120.50$117.00129,203
$118.50+2.00+1.7%$116.50$120.00$116.50116,551
$116.50-5.50-4.5%$124.50$124.50$114.00188,300
$122.000.000.0%$122.50$123.50$121.00130,001
$122.00-0.50-0.4%$120.50$127.50$120.00287,000
$122.50-1.00-0.8%$121.50$124.00$121.00157,100
$123.50-2.00-1.6%$126.00$126.00$120.00249,000
$125.50-7.50-5.6%$133.50$133.50$125.50415,265
$133.00-7.00-5.0%$137.00$140.50$129.50771,549
$140.00-2.00-1.4%$144.00$147.50$135.00787,141
$142.00+12.50+9.7%$128.50$142.00$128.50665,253
$129.50-6.50-4.8%$135.00$135.00$127.00698,203
$136.00-7.00-4.9%$140.50$142.00$132.00610,507
$143.00-5.50-3.7%$147.50$148.00$142.50535,345
$148.50+8.50+6.1%$140.00$149.00$140.00694,484
$140.00+2.00+1.4%$137.50$140.00$135.00314,643
$138.00+1.00+0.7%$135.50$138.00$134.50217,181
$137.00+2.00+1.5%$135.00$137.50$128.00466,229
$135.000.000.0%$130.50$137.50$130.50613,833
$135.00+3.00+2.3%$131.00$137.00$124.50941,000
$132.00+8.00+6.5%$119.50$132.00$114.001,190,299
$124.00+4.00+3.3%$119.50$130.00$118.001,754,510
$120.00+10.50+9.6%$114.50$120.00$110.50686,025
$109.50+9.70+9.7%$100.00$109.50$100.00805,900
$99.80+1.30+1.3%$98.50$99.80$96.50133,200
$98.500.000.0%$99.50$99.50$96.50174,000
$98.50+3.10+3.2%$95.10$98.50$94.70130,100
$95.40-0.40-0.4%$97.20$97.20$95.4068,100
$95.80+0.50+0.5%$94.60$96.70$94.6084,000
$95.30-0.30-0.3%$97.00$97.00$95.20120,000
$95.60-1.80-1.8%$95.70$97.00$95.0069,000
$97.40-0.20-0.2%$98.20$99.90$93.00156,500
$97.60+1.10+1.1%$96.50$97.90$95.00113,000
$96.50-1.80-1.8%$98.70$99.30$96.00310,340
$98.30-5.70-5.5%$105.00$105.50$98.00442,135
$104.00-3.00-2.8%$107.50$107.50$103.50164,012
$107.00+5.50+5.4%$103.00$109.00$103.00602,030
$101.50+1.50+1.5%$100.00$103.00$100.00167,039
$100.00-1.50-1.5%$101.00$102.00$99.6091,050
$101.500.000.0%$101.50$104.00$100.00230,000
$101.500.000.0%$103.50$104.50$100.50213,159
$101.50+2.00+2.0%$104.00$105.00$101.00132,039
Ticker
TPEx:6945
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

All AP Biosciences, Inc. news

AP Biosciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest May 11, 2026 · oldest 2026

Valuation

Price/book 4.0× against a median of 1.6×: 6th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$7.11B TWD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
4.0×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
AP Biosciences, Inc. · TPEX:6945US$282.2MUS$215.6Mn/an/an/a4.0×n/a0.0×n/a
Contineum Therapeutics, Inc. · NASDAQ:CTNMUS$286.1MUS$47.86Mn/an/an/a1.2×n/a0.0×1.53
TRex Bio, Inc. · NASDAQ:TRXBUS$283.1MUS$205.0Mn/an/an/an/an/an/an/a
Greenwich LifeSciences, Inc. · NASDAQ:GLSIUS$282.6MUS$276.7Mn/an/an/an/an/an/a2.80
Precision BioSciences, Inc. · NASDAQ:DTILUS$282.5MUS$228.3Mn/a5.1×n/a5.5×−85.6%0.5×0.30
Fulcrum Therapeutics, Inc. · NASDAQ:FULCUS$281.8M−US$17.87Mn/an/an/a0.9×n/a0.0×0.42
Circio Holding ASA · OSL:CRNAUS$281.1MUS$225.9Mn/an/an/a5.3×n/a0.0×n/a
Relmada Therapeutics, Inc. · NASDAQ:RLMDUS$279.5MUS$77.42Mn/an/an/a1.4×n/a0.0×1.57
Benitec Biopharma Inc. · NASDAQ:BNTCUS$276.1MUS$99.78Mn/an/an/a1.6×n/a0.0×1.46
Vicore Pharma Holding AB · OMXSTO:VICOUS$271.4MUS$182.7Mn/a467×n/a3.3×n/a0.0×n/a
Galectin Therapeutics Inc. · NASDAQ:GALTUS$271.4MUS$293.0Mn/an/an/an/an/an/a1.20
Median of the othersUS$281.5MUS$193.8M236×1.6×−85.6%0.0×1.46

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue0032.3M06.99M137.6M
Cost of revenue017.5M08.68M0
Gross profit0-17.5M32.3M-8.68M6.99M137.6K
Research and development369.8M365.4M336.6M262.7M173.8M66.8M
Selling, general and administrative86.6M73.1M43.1M34.8M19.9M
Operating income-456.4M-439.1M-347.5M-288.5M-186.7M45.0M
Depreciation and amortization25.5M17.5M12.6M8.68M8.86M7.20K
EBITDA-430.9M-421.6M-334.9M-279.9M-177.9M45.0M
Interest expense1.42M1.65M1.20M0
Income before tax-444.8M-422.7M-339.3M-288.5M-187.6M41.7M
Net income-444.8M-422.7M-339.3M-288.5M-187.6M41.7K
Earnings per share, basic-5.20-5.61-5.24-5.48-3.890.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents970.9M1.44B278.6M1.05B527.1M630.7K
Short-term investments200.0M100.0M461.4M30.7M30.0M
Receivables4.89M2.62M1.03M17.0K105
Current assets1.22B1.58B765.6M1.09B563.9M632.3K
Total assets1.37B1.73B890.8M1.10B579.3M652.0K
Current liabilities40.8M39.7M30.9M4.52M21.1M9.16K
Total debt70.9M82.1M
Total liabilities94.2M104.4M106.7M4.52M21.1M9.16K
Shareholders' equity1.27B1.62B784.1M1.10B558.2M642.9K
Shares outstanding85.6M75.3M64.7M52.6M48.2M48.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-352.1M-357.9M-297.6M-276.0M-168.7M-17.0K
Capital spending-25.3M-5.53M-35.4M-2.43M-4.91M-7.25K
Free cash flow-377.3M-363.4M-333.0M-278.4M-173.6M-24.3K
Cash from investing326.4M-468.7M-3.15M-34.9M-7.30K
Cash from financing1.20B-3.10M800.0M100.0M581.1K
Change in cash-470.8M1.16B-769.4M520.9M-103.6M556.8K

Open Financials

Cap table

Built by 6ix from AP Biosciences, Inc.’s releases

Common shares
95,704,160
Fully diluted
95,704,160

Fully diluted

LineShares
Common shares95,704,160

Share count over time

CountShares
Nov 22, 202695,704,160

Open Cap table

Shareholders

HolderSharesOf the companyAs of
台灣浩鼎生技股份有限公司23.2M23.8%Oct 31, 2026
長春投資股份有限公司3M3.1%Oct 31, 2026
何正宏888K0.91%Oct 31, 2026
游忠哲383K0.39%Oct 31, 2026
曾莞如72,0000.07%Oct 31, 2026
涂起強41,0000.04%Oct 31, 2026
欒君儀7,000<0.01%Oct 31, 2026
丁琬芳5,000<0.01%Oct 31, 2026
歐奕宏3,000<0.01%Oct 31, 2026
黃甫程1,000<0.01%Oct 31, 2026
All 16 holders
HolderSharesOf the companyAs of
陳雅琪00.00%Oct 31, 2026
林世銘00.00%Oct 31, 2026
蘇來守00.00%Oct 31, 2026
陳志全00.00%Oct 31, 2026
林滿玉00.00%Oct 31, 2026
台灣浩鼎生技股份有限公司Nov 22, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about AP Biosciences, Inc.